Human β-galactoside α-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity

Molecular and Cellular Biochemistry

Volumn 331, Issue 1-2, 2009, Pages 81-88

  Huang, Su ^a   Day, Travis W ^a   Choi, Mi Ran ^a   Safa, Ahmad R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 8; Ovarian cancer; Sialylation; Sialyltransferases; ST3Gal III; Taxol

Indexed keywords

BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE; CASPASE 3; CASPASE 8; PACLITAXEL; SIALYLTRANSFERASE; UNCLASSIFIED DRUG; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; CASPASE 9;

APOPTOSIS; ARTICLE; ATTENUATION; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OVARY CANCER; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; DRUG EFFECT; DRUG SCREENING; ENZYME INDUCTION; ENZYMOLOGY; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; ENZYME INDUCTION; FEMALE; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; SIALYLTRANSFERASES;

EID: 74049152002     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0147-9     Document Type: Article

References (50)

1. Fukuda M (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56:2237-2244
2. Haltiwanger RS, Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73:491-537. doi:10.1146/ annurev.biochem.73.011303.074043
3. Pinho S, Marcos NT, Ferreira B, Carvalho AS, Oliveira MJ, Santos-Silva F, Harduin-Lepers A, Reis CA (2007) Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer Lett 249:157-170 (Epub 2006 Sep 11)
4. Sperandio M, Frommhold D, Babushkina I, Ellies LG, Olson TS, Smith ML, Fritzsching B, Pauly E, Smith DF, Nobiling R, Linderkamp O, Marth JD, Ley K (2006) Alpha 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur J Immunol 36:3207-3215. doi:10.1002/eji.200636157 (Pubitemid 44932722)
5. Mandal C, Srinivasan GV, Chowdhury S, Chandra S, Mandal C, Schauer R, Mandal C (2008) High level of sialate-O-acetyl-transferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj J 3:3
6. Kean EL, Munster-Kuhnel AK, Gerardy-Schahn R (2004) CMP-sialic acid synthetase of the nucleus. Biochim Biophys Acta 1673:56-65
7. Dall'Olio F, Chiricolo M (2001) Sialyltransferases in cancer. Glycoconj J 18:841-850. doi:10.1023/A:1022288022969 (Pubitemid 36315048)
8. Chen CL, Lee WL, Tsai YC, Yuan CC, Ng HT, Wang PH (2002) Sialyltransferase family members and cervix squamous cell carcinoma. Eur J Gynaecol Oncol 23:514-518
9. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318
10. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, Petrescu SM, Dwek RA, Rudd PM (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17:1344-1356 (Epub 2007 Sep 20)
11. Gorelik E, Galili U, Raz A (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 20:245-277. doi:10.1023/A: 1015535427597
12. Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH, Tsai YC (2005) Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol 96:415-422. doi:10.1016/j.ygyno.2004.10.010 (Pubitemid 40127143)
13. Brooks SA, Carter TM, Royle L, Harvey DJ, Fry SA, Kinch C, Dwek RA, Rudd PM (2008) Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med Chem 8:2-21. doi:10.2174/1871520 08783330860
14. Oei AL, Moreno M, Verheijen RH, Sweep FC, Thomas CM, Massuger LF, von Mensdorff-Pouilly S (2008) Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer. Int J Cancer 123:1848-1853. doi:10.1002/ijc. 23725
15. Wang PH, Li YF, Juang CM, Lee YR, Chao HT, Ng HT, Tsai YC, Yuan CC (2002) Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis. Gynecol Oncol 86:45-52. doi:10.1006/ gyno.2002.6714
16. Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P (1998) Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 58:4066-4070
17. Gretschel S, Haensch W, Schlag PM, Kemmner W (2003) Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology 65:139-145. doi:10.1159/0000 72339
18. Crown J, O'Leary M, Ooi WS (2004) Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9:24-32. doi:10.1634/theoncologist.9-suppl-2-24
19. Fields AL, Runowicz CD (2003) Current therapies in ovarian cancer. Cancer Invest 21:148-156. doi:10.1081/CNV-120016409 (Pubitemid 36292514)
20. Runowicz CD, Wiernik PH, Einzig AI, Goldberg GL, Horwitz SB (1993) Taxol in ovarian cancer. Cancer 71:1591-1596
21. Simon GR, Bunn PA Jr (2003) Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments. Cancer Invest 21:87-104. doi:10.1081/ CNV-120005919
22. Amadori D, Cecconetto L (2006) Gemcitabine and taxanes in metastatic breast cancer. Ann Oncol 17:v173-v176. doi: 10.1093/annonc/mdj976 (Pubitemid 43985230)
23. Rossi D, Dennetta D, Ugolini M, Alessandroni P, Catalano V, Fedeli SL, Giordani P, Casadei V, Baldelli AM, Graziano F, Catalano G (2008) Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study. Clin Lung Cancer 9:280-284. doi:10.3816/CLC.2008.n.043
24. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253-265. doi:10.1038/nrc1317
25. Liao PC, Lieu CH (2005) Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sci 76:1623-1639 (Epub 2005 Jan 20)
26. Huisman C, Ferreira CG, Broker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G (2002) Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin Cancer Res 8:596-606
27. Ofir R, Seidman R, Rabinski T, Krup M, Yavelsky V, Weinstein Y, Wolfson M (2002) Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent. Cell Death Differ 9:636-642. doi:10.1038/ sj.cdd.4401012
28. Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK (2008) Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia 10:1259-1267
29. Cao C, Lu S, Sowa A, Kivlin R, Amaral A, Chu W, Yang H, Di W, Wan Y (2008) Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs. Cancer Lett 266:249-262 (Epub 2008 Apr 8)
30. Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH (2008) NO signaling confers cytoprotectivity through the surviving network in ovarian carcinomas. Cancer Res 68:5159-5166. doi: 10.1158/0008-5472.CAN-08-0406
31. Duan Z, Weinstein EJ, Ji D, Ames RY, Choy E, Mankin H, Hornicek FJ (2008) Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer. Mol Cancer Ther 7:2377-2385 (Epub 2008 Aug 7)
32. Grahn A, Barkhordar GS, Larson G (2002) Cloning and sequencing of nineteen transcript isoforms of the human alpha2,3-sialyltransferase gene, ST3Gal III; its genomic organisation and expression in human tissues. Glycoconj J 19:197-210. doi: 10.1023/A:1024253808424 (Pubitemid 36851263)
33. Ahn HJ, Kim YS, Kim JU, Han SM, Shin JW, Yang HO (2004) Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem 91:1043-1052. doi:10.1002/jcb. 20006
34. Day TW, Najafi F, Wu CH, Safa AR (2006) Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis. Biochem Pharmacol 71:1551-1561 (Epub 2006 Mar 31)
35. Motwani M, Delohery TM, Schwartz GK (1999) Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin Cancer Res 5:1876-1883
36. Goncalves A, Braguer D, Carles G, Andre N, Prevot C, Briand C (2000) Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4). Biochem Pharmacol 60:1579-1584. doi: 10.1016/S0006-2952(00)00481-0
37. Oyaizu H, Adachi Y, Taketani S, Tokunaga R, Fukuhara S, Ikehara S (1999) A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis. Mol Cell Biol Res Commun 2:36-41. doi:10.1006/mcbr.1999.0146
38. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dorken B, Daniel PT (2003) Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 22:2236-2247. doi: 10.1038/sj.onc.1206280 (Pubitemid 36566780)
39. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR (2004) Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279:51057-51067. doi:10.1074/jbc.M406543200 (Pubitemid 40017847)
40. Biswas RS, Cha HJ, Hardwick JM, Srivastava RK (2001) Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL. Mol Cell Biochem 225:7-20. doi:10.1023/A:1012203110027 (Pubitemid 33014628)
41. Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dorken B, Daniel PT (2001) Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97:1378-1387. doi:10.1182/blood.V97.5.1378 (Pubitemid 32183762)
42. Perkins CL, Fang G, Kim CN, Bhalla KN (2000) The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 60:1645-1653
43. Razandi M, Pedram A, Levin ER (2000) Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14:1434-1447. doi:10.1210/me.14.9.1434
44. Perkins C, Kim CN, Fang G, Bhalla KN (1998) Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res 58:4561-4566
45. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK (2003) Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 1:66. doi:10.1186/ 1477-7827-1-66
46. Richardson A, Kaye SB (2005) Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance. Drug Resist Updat 8:311-321 (Epub 2005 Oct 17)
47. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P (2001) The human sialyltransferase family. Biochimie 83:727-737. doi:10.1016/S0300-9084(01)01301-3 (Pubitemid 32821237)
48. Harduin-Lepers A, Recchi MA, Delannoy P (1995) 1994, the year of sialyltransferases. Glycobiology 5:741-758. doi:10.1093/ glycob/5.8.741
49. Tsuji S, Datta AK, Paulson JC (1996) Systematic nomenclature for sialyltransferases. Glycobiology 6:5-7. doi:10.1093/glycob/ 6.7.647
50. Kitagawa H, Paulson JC (1993) Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun 194:375-382. doi:10.1006/bbrc.1993. 1830